Humana Statistics
Total Valuation
Humana has a market cap or net worth of $42.77 billion. The enterprise value is $33.74 billion.
| Market Cap | 42.77B |
| Enterprise Value | 33.74B |
Important Dates
The last earnings date was Wednesday, April 24, 2024, before market open.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
Humana has 120.50 million shares outstanding. The number of shares has decreased by -3.46% in one year.
| Shares Outstanding | 120.50M |
| Shares Change (YoY) | -3.46% |
| Shares Change (QoQ) | -2.00% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 93.61% |
| Float | 120.12M |
Valuation Ratios
The trailing PE ratio is 21.91 and the forward PE ratio is 19.48. Humana's PEG ratio is 1.64.
| PE Ratio | 21.91 |
| Forward PE | 19.48 |
| PS Ratio | 0.39 |
| Forward PS | 0.37 |
| PB Ratio | 2.65 |
| P/FCF Ratio | n/a |
| PEG Ratio | 1.64 |
Enterprise Valuation
| EV / Earnings | 16.95 |
| EV / Sales | 0.31 |
| EV / EBITDA | 8.04 |
| EV / EBIT | 10.36 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.84.
| Current Ratio | 1.67 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | n/a |
| Interest Coverage | 6.04 |
Financial Efficiency
Return on equity (ROE) is 12.00% and return on invested capital (ROIC) is 8.71%.
| Return on Equity (ROE) | 12.00% |
| Return on Assets (ROA) | 3.80% |
| Return on Capital (ROIC) | 8.71% |
| Revenue Per Employee | $1.62M |
| Profits Per Employee | $29,453 |
| Employee Count | 67,600 |
| Asset Turnover | 2.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $728.00 million in taxes.
| Income Tax | 728.00M |
| Effective Tax Rate | 26.77% |
Stock Price Statistics
The stock price has decreased by -30.92% in the last 52 weeks. The beta is 0.50, so Humana's price volatility has been lower than the market average.
| Beta (1Y) | 0.50 |
| 52-Week Price Change | -30.92% |
| 50-Day Moving Average | 330.66 |
| 200-Day Moving Average | 425.75 |
| Relative Strength Index (RSI) | 70.48 |
| Average Volume (30 Days) | 1,694,141 |
Short Selling Information
The latest short interest is 3.24 million, so 2.69% of the outstanding shares have been sold short.
| Short Interest | 3.24M |
| Short Previous Month | 2.45M |
| Short % of Shares Out | 2.69% |
| Short % of Float | 2.69% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
In the last 12 months, Humana had revenue of $109.24 billion and earned $1.99 billion in profits. Earnings per share was $16.22.
| Revenue | 109.24B |
| Gross Profit | 17.58B |
| Operating Income | 3.53B |
| Pretax Income | 2.72B |
| Net Income | 1.99B |
| EBITDA | 4.20B |
| EBIT | 3.26B |
| Earnings Per Share (EPS) | $16.22 |
Balance Sheet
The company has $22.61 billion in cash and $13.55 billion in debt, giving a net cash position of $9.06 billion or $75.20 per share.
| Cash & Cash Equivalents | 22.61B |
| Total Debt | 13.55B |
| Net Cash | 9.06B |
| Net Cash Per Share | $75.20 |
| Equity / Book Value | 16.13B |
| Book Value Per Share | 133.86 |
| Working Capital | 13.11B |
Cash Flow
In the last 12 months, operating cash flow was -$2.28 billion and capital expenditures -$748.00 million, giving a free cash flow of -$3.03 billion.
| Operating Cash Flow | -2.28B |
| Capital Expenditures | -748.00M |
| Free Cash Flow | -3.03B |
| FCF Per Share | -$25.12 |
Margins
Gross margin is 16.10%, with operating and profit margins of 3.23% and 1.82%.
| Gross Margin | 16.10% |
| Operating Margin | 3.23% |
| Pretax Margin | 2.49% |
| Profit Margin | 1.82% |
| EBITDA Margin | 3.84% |
| EBIT Margin | 2.98% |
| FCF Margin | -2.77% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 1.00%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 1.00% |
| Dividend Growth (YoY) | 5.83% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 21.82% |
| Buyback Yield | 3.46% |
| Shareholder Yield | 4.45% |
| Earnings Yield | 4.65% |
| FCF Yield | -7.08% |
Analyst Forecast
The average price target for Humana is $420.00, which is 18.36% higher than the current price. The consensus rating is "Buy".
| Price Target | $420.00 |
| Price Target Difference | 18.36% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 6.96% |
| EPS Growth Forecast (5Y) | 15.21% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Humana has an Altman Z-Score of 4.25 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.25 |
| Piotroski F-Score | 5 |